SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2025 on March 3, 2026

Rhea-AI Summary

SOPHiA GENETICS (Nasdaq: SOPH) will release fourth-quarter and full-year 2025 financial results before U.S. markets open on March 3, 2026. A conference call to discuss results and business outlook will begin at 8:00 AM EDT / 2:00 PM CET and will be webcast on the company investor relations website. A replay will be available after the call.

News Market Reaction – SOPH

+0.21%

3 alerts

+0.21% Session close to close

$340.93M Market Cap

0.1x Rel. Volume

In the Feb 17 session, SOPH gained 0.21%, reflecting a mild positive market reaction. Our momentum scanner triggered 3 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement schedules the release of SOPHiA GENETICS’ fourth quarter and full year 2025 result...

Analysis

This announcement schedules the release of SOPHiA GENETICS’ fourth quarter and full year 2025 results for March 3, 2026, with a conference call at 8:00 a.m. EDT / 2:00 p.m. CET. It follows earlier preliminary figures and guidance, signaling the point when audited numbers and fuller commentary will be available. Investors may look to compare those final results to prior updates, recent partnerships, and financing developments to assess execution and outlook.

Key Figures

Earnings release date: March 3, 2026 Quarter reported: Fourth quarter 2025 Full year reported: Full year 2025 +2 more

5 metrics

Earnings release date March 3, 2026 Q4 and full year 2025 results release before U.S. market open

Quarter reported Fourth quarter 2025 Scheduled financial results to be discussed on March 3, 2026

Full year reported Full year 2025 Scheduled financial results to be discussed on March 3, 2026

Conference call time EDT 8:00 a.m. EDT Start time for earnings conference call

Conference call time CET 2:00 p.m. CET Start time for earnings conference call in Europe

Historical Context

5 past events · Latest: Feb 10 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Feb 10	US expansion deal	Positive	-1.4%	Signed two major U.S. integrated health systems for SOPHiA DDM platform.
Jan 15	Innovation awards	Positive	+0.2%	Company recognized with six BIG Innovation Awards across product lines.
Jan 12	Prelim earnings, guidance	Positive	-2.6%	Preliminary Q4/FY 2025 results, 2026 guidance, and executive transition plan.
Jan 07	Oncology collaboration	Positive	+4.2%	Strategic collaboration with MD Anderson for AI-driven precision oncology.
Nov 11	Platform integration	Positive	+6.2%	Integration of MSK assays on DNBSEQ-T1+ platform for precision oncology.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent SOPH-specific news skews positive, but share reactions have been mixed, with both aligned gains on collaborations and integrations and divergences on commercial and preliminary earnings updates.

Recent Company History

Over the last several months, SOPH has reported multiple strategic and commercial milestones. On Nov 11, 2025, it highlighted an assay integration with Complete Genomics, followed by a strategic collaboration with MD Anderson on Jan 7, 2026. Preliminary Q4 and FY 2025 results with 2026 guidance and an executive transition were released on Jan 12, 2026. A major U.S. network expansion was announced on Feb 10, 2026. Today’s earnings date announcement on March 3, 2026, connects back to those preliminary figures, setting expectations for final audited results.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BOSTON and ROLLE, Switzerland, Feb. 17, 2026 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today announced it will release its financial results for the fourth quarter and full year 2025 before U.S. markets open on Tuesday, March 3, 2026. On that day, SOPHiA GENETICS will host a conference call to discuss its financial results as well as business outlook beginning at 8:00 a.m. (08:00) EDT / 2:00 p.m. (14:00) CET.

The call will be webcast live on the SOPHiA GENETICS Investor Relations Website. Additionally, a replay will be available on the website after its completion.

About SOPHiA GENETICS

SOPHiA GENETICS (Nasdaq: SOPH) is a software company on a mission to expand access to data-driven medicine by using AI to deliver world-class care to patients with cancer and rare disorders across the globe. It is the creator of the SOPHiA DDM™ Platform, a cloud-native platform that analyzes complex multimodal data – including genomics, radiomics, clinical, biological, and digital pathology data – to generate real-time, actionable insights for a broad global network of hospital, laboratory, and biopharma institutions. For more information, visit SOPHiAGENETICS.COM and connect with us on LinkedIn.

View original content to download multimedia:https://www.prnewswire.com/news-releases/sophia-genetics-to-announce-financial-results-for-fourth-quarter-and-full-year-2025-on-march-3-2026-302687934.html

SOURCE SOPHiA GENETICS

FAQ

When will SOPH report fourth-quarter and full-year 2025 results?

SOPHiA GENETICS will release Q4 and full-year 2025 results before U.S. markets open on March 3, 2026. According to the company, the announcement precedes a conference call discussing the results and business outlook the same day at 8:00 AM EDT.

What time is the SOPH conference call on March 3, 2026?

The SOPHiA GENETICS conference call starts at 8:00 AM EDT / 2:00 PM CET on March 3, 2026. According to the company, the live webcast will be accessible via the SOPHiA GENETICS investor relations website, with a replay available afterward.

How can investors listen to the SOPH March 3, 2026 earnings call?

Investors can listen via the live webcast on the SOPHiA GENETICS investor relations website. According to the company, the webcast will stream the conference call and a replay will be posted on the same website after the call concludes.

Will a replay be available for the SOPH earnings call on March 3, 2026?

Yes, a replay of the SOPHiA GENETICS conference call will be available on the investor relations website after completion. According to the company, the replay will allow investors to review the discussion of fourth-quarter and full-year 2025 results and outlook.

What will the SOPH March 3, 2026 call cover besides financial results?

The call will discuss the companys business outlook in addition to fourth-quarter and full-year 2025 financial results. According to the company, management will present results and provide forward-looking commentary during the webcast on March 3, 2026.